Results 191 to 200 of about 34,817 (256)

Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions. [PDF]

Endocr Connect
Hu W, Zhu H, Gong F.
europepmc   +1 more source

MON-101 The LD Lync Study: Natural History Study of Lipodystrophy Syndromes: Early Lessons from the Pilot Data

, 2019
Abdelwahab Jalal Eldin, Barış Akıncı, Rasimcan Meral, Diana Rus, Mario Swaidan, Rita Hench, Adam Neidert, Andra Stratton, Cathie Spino, Elif A Oral   +9 more
openalex   +1 more source

The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions. [PDF]

Front Endocrinol (Lausanne)
Brown RJ, Akinci B, Al Yaarubi S, Bismuth E, Cappa M, Deeb A, Kamrath C, Musso C, Patni N, Prodam F, Williams R, Wabitsch M.   +11 more
europepmc   +1 more source

Genes affecting triglyceride metabolism from steatosis to lipodystrophy

, 2001
Houshang Monajemi
openalex   +1 more source

Non HIV-Associated Buffalo Hump as a Clinical Marker of Metabolic Disease. [PDF]

J Clin Med
Lee NH, Lim BJ, Shin JY, Chung YK, Roh SG.   +4 more
europepmc   +1 more source

Metreleptin In SHORT Syndrome With Uncontrolled Diabetes. [PDF]

JCEM Case Rep
Korakas E, Kountouri A, Ikonomidis I, Georgiou I, Akinci B, Lambadiari V.   +5 more
europepmc   +1 more source

Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2. [PDF]

J Clin Invest
Maung JN, Schill RL, Nishii A, Foss de Freitas M, Obua BN, Nygård M, Mendez-Casillas MD, Hermsmeyer ID, Gilio D, Besci O, Chen Y, Desrosiers B, Adler RE, Gomes AD, Celik Guler M, Mori H, Uranga RM, Li Z, Hariri H, Zhang L, de Paula Souza A, Hoose KS, Lewis KT, Hetrick TA, Cederna P, Lumeng CN, Mandrup S, Oral EA, MacDougald OA.   +28 more
europepmc   +1 more source

Coincidence of Autoimmune Diabetes Mellitus and Familial Partial Lipodystrophy. [PDF]

JCEM Case Rep
Krienke M, Schmidt HHJ, Buettner J, Tan S, Schumann I, Miehle K.   +5 more
europepmc   +1 more source

Long-Term Clinical Experience With Metreleptin in a Brazilian Patient With Congenital Generalized Lipodystrophy Type 2. [PDF]

JCEM Case Rep
Sued Leão I, Rodrigues Dantas J, Galvão S, Rodacki M, Zajdenverg L.   +4 more
europepmc   +1 more source

A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemia. [PDF]

J Clin Invest
Simha V, LoPiccolo MK, Platt A, Brown RJ, Johnson X, Carere DA, Donnelly C, Snyder MT, Xing C, Mathews TP, Gopal P, Ward SC, Tomchick DR, Agarwal AK, DeBerardinis RJ, Garg A.   +15 more
europepmc   +1 more source